Osteoporosis risk with sodium-glucose cotransporter 2 inhibitors versus thiazolidinediones in older women with diabetes
{{output}}
Introduction: This study aimed to compare the risk of osteoporosis between sodium-glucose cotransporter 2 inhibitors (SGLT2is) and thiazolidinediones (TZDs) in older women with type 2 diabetes (T2D). ... ...
